DeHaven-Hudkins DL - Search Results

1

[3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.

DeHaven-Hudkins DL, Daubert JD, Sawutz DG, Tiberio L, Baine Y. DeHaven-Hudkins DL, et al. Immunopharmacology. 1996 Oct;35(1):27-39. doi: 10.1016/0162-3109(96)00107-5. Immunopharmacology. 1996. PMID: 8913792

2

Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.

DeHaven-Hudkins DL, Fleissner LC. DeHaven-Hudkins DL, et al. Life Sci. 1992;50(9):PL65-70. doi: 10.1016/0024-3205(92)90255-n. Life Sci. 1992. PMID: 1346920

3

Binding of dexetimide and levetimide to [3H](+)pentazocine- and [3H]1,3-di(2-tolyl)guanidine-defined sigma recognition sites.

DeHaven-Hudkins DL, Hudkins RL. DeHaven-Hudkins DL, et al. Life Sci. 1991;49(18):PL135-9. doi: 10.1016/0024-3205(91)90203-n. Life Sci. 1991. PMID: 1656155

4

Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.

DeHaven-Hudkins DL, Fleissner LC, Ford-Rice FY. DeHaven-Hudkins DL, et al. Eur J Pharmacol. 1992 Dec 1;227(4):371-8. doi: 10.1016/0922-4106(92)90153-m. Eur J Pharmacol. 1992. PMID: 1359973

5

Sigma receptor binding affinity and inhibition of apomorphine-induced climbing.

Fritz PM, DeHaven-Hudkins DL, Fleissner LC, Ford-Rice FY, Luttinger D. Fritz PM, et al. Eur J Pharmacol. 1993 Apr 28;235(2-3):229-35. doi: 10.1016/0014-2999(93)90141-4. Eur J Pharmacol. 1993. PMID: 8508904

6

Arylacetamides as peripherally restricted kappa opioid receptor agonists.

Kumar V, Marella MA, Cortes-Burgos L, Chang AC, Cassel JA, Daubert JD, DeHaven RN, DeHaven-Hudkins DL, Gottshall SL, Mansson E, Maycock AL. Kumar V, et al. Bioorg Med Chem Lett. 2000 Nov 20;10(22):2567-70. doi: 10.1016/s0960-894x(00)00519-9. Bioorg Med Chem Lett. 2000. PMID: 11086731

7

sigma recognition sites in brain and peripheral tissues. Characterization and effects of cytochrome P450 inhibitors.

DeHaven-Hudkins DL, Lanyon LF, Ford-Rice FY, Ator MA. DeHaven-Hudkins DL, et al. Biochem Pharmacol. 1994 Mar 29;47(7):1231-9. doi: 10.1016/0006-2952(94)90395-6. Biochem Pharmacol. 1994. PMID: 8161352

8

Antipruritic and antihyperalgesic actions of loperamide and analogs.

DeHaven-Hudkins DL, Cowan A, Cortes Burgos L, Daubert JD, Cassel JA, DeHaven RN, Kehner GB, Kumar V. DeHaven-Hudkins DL, et al. Life Sci. 2002 Oct 25;71(23):2787-96. doi: 10.1016/s0024-3205(02)02102-1. Life Sci. 2002. PMID: 12383884

9

Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.

Kumar V, Guo D, Cassel JA, Daubert JD, Dehaven RN, Dehaven-Hudkins DL, Gauntner EK, Gottshall SL, Greiner SL, Koblish M, Little PJ, Mansson E, Maycock AL. Kumar V, et al. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1091-5. doi: 10.1016/j.bmcl.2004.12.018. Bioorg Med Chem Lett. 2005. PMID: 15686919

10

Amino acid conjugates as kappa opioid receptor agonists.

Kumar V, Guo D, Daubert JD, Cassel JA, DeHaven RN, Mansson E, DeHaven-Hudkins DL, Maycock AL. Kumar V, et al. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1279-82. doi: 10.1016/j.bmcl.2005.01.038. Bioorg Med Chem Lett. 2005. PMID: 15713370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters